文献速递头颈外科

HPV相关口咽癌TORS术后质子放疗利用差异

Disparities in Proton Radiation Utilization for HPV-Associated Oropharyngeal Cancer Following TORS.
PubMed 文献 · Head Neck · 2025-12-04

本研究回顾2016-2023年接受TORS及辅助放疗的HPV相关口咽鳞癌患者,分析质子放疗利用的差异。

要点

  • 较高中位收入与质子放疗利用显著相关(p=0.04)。
  • 年龄、性别、种族、肿瘤分期、保险等与质子放疗无显著关联。
  • 本队列以私人保险的白人男性为主,质子治疗可及性似较公平。

核心结论

  • 较高中位收入与质子放疗利用显著相关,其他传统差异因素在本队列中不明显。

研究设计与样本

  • 回顾性队列研究,纳入2016-2023年接受TORS及辅助放疗的HPV相关OPSCC患者116例。

主要发现

  • 116例中102例(87.9%)为男性,105例(90.5%)为白人,中位年龄59.7岁。
  • 较高中位收入与质子放疗显著相关(p=0.04)。

关键数值与推荐

  • 年龄、性别、种族、肿瘤亚部位、T和N分期、保险、就业及距机构距离与质子放疗无显著关联。

临床怎么用

  • 在本以私人保险白人男性为主的队列中,质子辅助放疗的可及性跨人口学特征似较公平。

局限性

  • 队列以私人保险的白人男性为主,可能限制对其他人群的推广。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Racial, socioeconomic, and geographic disparities in receipt of proton radiation have been reported. Whether disparities exist for oropharyngeal squamous cell carcinoma (OPSCC) is not well studied. METHODS: Patients with HPV-associated OPSCC treated with transoral robotic surgery (TORS) and adjuvant radiation from 2016 to 2023 were reviewed. Demographics, disease characteristics, treatment details, and socioeconomic variables were collected. RESULTS: Of 116 patients, 102 (87.9%) were male, 105 (90.5%) White, with a median age of 59.7 years. Fifty (43.1%) received proton radiation. Age, gender, race, tumor subsite, tumor and nodal staging, insurance, employment, and distance from our institution were not significantly associated with proton radiation, while higher median income was (p = 0.04). CONCLUSION: While higher median income was significantly associated with proton radiation, other traditionally described disparities were not apparent for HPV-associated OPSCC treated with TORS. Although this cohort included predominantly privately insured White males, access to adjuvant proton therapy seemed to be equitably available across demographics.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Tong JY, Bzhilyanskaya V, Molitoris JK, et al. Disparities in Proton Radiation Utilization for HPV-Associated Oropharyngeal Cancer Following TORS. Head Neck. 2025. PMID: 41346079. doi:10.1002/hed.70122

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。